CFN Enterprises (OTCMKTS:CNFN – Get Free Report) and OptimizeRx (NASDAQ:OPRX – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.
Valuation & Earnings
This table compares CFN Enterprises and OptimizeRx”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
CFN Enterprises | $3.54 million | 8.13 | -$15.19 million | ($0.19) | -1.84 |
OptimizeRx | $92.13 million | 1.65 | -$17.57 million | ($1.10) | -7.52 |
CFN Enterprises has higher earnings, but lower revenue than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than CFN Enterprises, indicating that it is currently the more affordable of the two stocks.
Profitability
Net Margins | Return on Equity | Return on Assets | |
CFN Enterprises | -67.36% | N/A | -53.19% |
OptimizeRx | -27.41% | -4.92% | -3.41% |
Volatility and Risk
CFN Enterprises has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and recommmendations for CFN Enterprises and OptimizeRx, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
CFN Enterprises | 0 | 0 | 0 | 0 | 0.00 |
OptimizeRx | 0 | 3 | 5 | 1 | 2.78 |
OptimizeRx has a consensus price target of $9.06, suggesting a potential upside of 9.58%. Given OptimizeRx’s stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than CFN Enterprises.
Insider and Institutional Ownership
76.5% of OptimizeRx shares are held by institutional investors. 40.8% of CFN Enterprises shares are held by company insiders. Comparatively, 6.1% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
OptimizeRx beats CFN Enterprises on 9 of the 15 factors compared between the two stocks.
About CFN Enterprises
CFN Enterprises Inc. engages in the sponsored content and marketing business in the United States. The company sets up and manages compliant and turnkey ad campaigns, as well as runs sponsored content, including articles, press releases, videos, podcasts, advertisements and other media, email advertisements, and other marketing campaigns for public and private companies. It also operates various media platforms, including CannabisFN.com, CFNMediaNews.com, and other venues to educate and inform investors interested in the cannabis industry; and distributes content across various online platforms, such as the CannabisFN.com website, press releases, financial news syndicates, search engines, YouTube, iTunes, Instagram, X, Facebook, LinkedIn, and others. In addition, the company is involved in the white label manufacturing and co-packing business; and cannabidiol manufacturing business. It serves cannabis, hemp, and wellness industries. The company was formerly known as Accelerize Inc. and changed its name to CFN Enterprises Inc. in October 2019. CFN Enterprises Inc. was founded in 2001 and is based in Whitefish, Montana.
About OptimizeRx
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Receive News & Ratings for CFN Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CFN Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.